Impel NeuroPharma (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- December 06, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $67,500,000
Company Info
- Company Description
- Impel NeuroPharma is a privately-held, biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases.
- Market
- Central Nervous System Diseases
- Location
- Seattle, WA, USA
- Coinvestors
- 5AM Ventures, KKR, Norwest Venture Partners, VenBio, Vivo Capital